ArticleJournal for immunotherapy of cancer2020

EPHA mutation as a predictor of immunotherapeutic efficacy in lung adenocarcinoma.

Hua Bai et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.